Moderna's (MRNA) new COVID-19 shot, mRNA-1283, shows promising results in Phase 3 trials, with comparable efficacy and safety to its approved vaccine. Read more here.
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
There are still multiple steps required before the shot would become available. Moderna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to ...
CAMBRIDGE - Moderna announced Monday that its combination COVID and flu vaccine showed positive results in a late-stage trial ...
Trial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases superior, to the company’s initial COVID vaccine.
Moderna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to getting the flu and COVID shots separately, according to the company's results ...